Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity.

Smith, Stephanie

Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity. [electronic resource] - PloS one 2014 - e87203 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

1932-6203

10.1371/journal.pone.0087203 doi


Animals
Antigens, Nuclear--genetics
B-Lymphocytes--cytology
Blotting, Western
Cell Survival--drug effects
Cells, Cultured
Chickens
DNA Damage--drug effects
DNA End-Joining Repair--drug effects
DNA Repair--drug effects
DNA-Binding Proteins--antagonists & inhibitors
Electrophoresis, Gel, Pulsed-Field
Fluorescent Antibody Technique
Histone Deacetylase Inhibitors--pharmacology
Humans
Hydroxamic Acids--pharmacology
Ku Autoantigen
Luciferases--metabolism
Mutation--genetics
Neoplasms--drug therapy
RNA, Small Interfering--genetics
Rad51 Recombinase--antagonists & inhibitors
RecQ Helicases--genetics
Vorinostat